Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled dose-finding study of BW-201 (Adj 1) in adults aged 60 years and older
CTR20253815Phase 2Active
- Sponsor
- Baiyi Wuyou
- Start
- Nov 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BW-201 in respiratory syncytial virus lower respiratory tract infection, sponsored by Baiyi Wuyou. Started Nov 2025; status: active.
02
Drugs
BW-201
03
Conditions
respiratory syncytial virus lower respiratory tract infection
Beyond the preview
Go deeper on CTR20253815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253815.